The Role of WDR77 in Cancer: More than a PRMT5 Interactor

Area of Science:

• Molecular Biology
• Cancer Biology
• Cellular Signaling

Background:

• WD repeat domain 77 protein (WDR77) is implicated in cancer progression.
• WDR77's known function involves interaction with protein arginine methyltransferase 5 (PRMT5) in histone methylation.
• Emerging evidence suggests WDR77 has roles beyond PRMT5, impacting various cellular processes.

Purpose of the Study:

• To elucidate the multifaceted roles of WDR77 in cancer.
• To explore WDR77's functions independent of its interaction with PRMT5.
• To highlight WDR77 as a potential therapeutic target in oncology.

Main Methods:

• Literature review and analysis of WDR77's known interactions and functions.
• Examination of WDR77's involvement in mRNA translation, chromatin assembly, cell-cycle regulation, and apoptosis.
• Investigation of WDR77's role in signaling pathways like TGFβ and its interaction with transcription factors (e.g., E2F) and hormone receptors.

Main Results:

• WDR77 regulates cell-cycle progression, particularly the G1 phase transition.
• WDR77 influences diverse oncogenic pathways, including TGFβ signaling and steroid hormone receptor activity.
• WDR77 exhibits context-dependent dual roles, promoting or inhibiting tumor growth based on its cellular localization (nucleus vs. cytoplasm).

Conclusions:

• WDR77 possesses broad oncogenic potential through various cellular mechanisms, independent of PRMT5.
• The dynamic and context-specific functions of WDR77 present it as a promising therapeutic target.
• Targeting WDR77 interactions or localization could lead to novel cancer treatment strategies.